Cross-Validation of Everolimus LC-MS/MS and Thermo Fisher QMS Therapeutic Drug Monitoring Assays-The Zortracker Cross-Validation and TDM Support Program

被引：0
|
作者：
Meyer, E. J. [1 ]
Schniedewind, B. [2 ]
Boucher, R. [2 ]
Johnson-Davis, K. L. [3 ]
Galinkin, J. L. [2 ,4 ]
Christians, U. [2 ]
机构：
[1] Novartis Pharmaceut, East Hannover, NJ USA
[2] Univ Colorado, Clin Res & Dev IC42, Aurora, CO USA
[3] Univ Utah, ARUP Labs, Salt Lake City, UT USA
[4] CPC Clin Res, Aurora, CO USA
来源：
THERAPEUTIC DRUG MONITORING | 2013年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：702 / 702
页数：1
相关论文
共 30 条
  • [1] Long-Term Cross-Validation of Everolimus Therapeutic Drug Monitoring Assays: The Zortracker Study
    Schniedewind, Bjoern
    Niederlechner, Stefanie
    Galinkin, Jeffrey L.
    Johnson-Davis, Kamisha L.
    Christians, Uwe
    Meyer, Eric J.
    THERAPEUTIC DRUG MONITORING, 2015, 37 (03) : 296 - 303
  • [2] Cross Validation of the Thermo Fisher QMS Everolimus Therapeutic Drug Monitoring Assay Run on Four Different Immunoassay Analyzer Platforms With Ten Global LC-MS/MS Laboratories
    Christians, U.
    Schniedewind, B.
    Billaud, E.
    Poinsignon, V
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 702 - 702
  • [3] Fit-for-purpose bioanalytical cross-validation for LC-MS/MS assays in clinical studies
    Xu, Xiaohui
    Ji, Qin C.
    Jemal, Mohammed
    Gleason, Carol
    Shen, Jim X.
    Stouffer, Bruce
    Arnold, Mark E.
    BIOANALYSIS, 2013, 5 (01) : 83 - 90
  • [4] The use of methods based on LC-MS/MS for establishing the specificity of radioimmunoassays by cross-validation
    Gilbert, JD
    JOURNAL OF CLINICAL LIGAND ASSAY, 1997, 20 (01): : 23 - 31
  • [5] Bioanalytical LC-MS/MS validation of therapeutic drug monitoring assays in oncology
    van Nuland, Merel
    Rosing, Hilde
    Schellens, Jan H. M.
    Beijnen, Jos H.
    BIOMEDICAL CHROMATOGRAPHY, 2020, 34 (01)
  • [6] The use of methods based on LC-MS/MS for establishing the specificity of radioimmunoassays by cross-validation (vol 20, pg 23, 1997)
    Gilbert, JD
    JOURNAL OF CLINICAL LIGAND ASSAY, 1997, 20 (02): : 211 - 211
  • [7] Cross-Validation of a Multiplex LC-MS/MS Method for Assaying mAbs Plasma Levels in Patients with Cancer: A GPCO-UNICANCER Study
    Marin, Clemence
    Khoudour, Nihel
    Millet, Aurelien
    Lebert, Dorothee
    Bros, Pauline
    Thomas, Fabienne
    Ternant, David
    Lacarelle, Bruno
    Guitton, Jerome
    Ciccolini, Joseph
    Blanchet, Benoit
    PHARMACEUTICALS, 2021, 14 (08)
  • [8] CROSS-VALIDATION OF LC-MS/MS AND ELISA TECHNIQUES FOR THE QUANTIFICATION OF PLASMA CYCLIC GUANOSINE 3′, 5′-MONOPHOSPHATE (CGMP) FOR CLINICAL APPLICATIONS
    Zhang, Yanhua
    Dufield, Dawn
    Klover, Jon
    Li, Wenlin
    Szekely-Klepser, Gabriella
    Lepsy, Christopher
    Sadagopan, Nalini
    DRUG METABOLISM REVIEWS, 2008, 40 : 40 - 40
  • [9] Quantification and validation of HPLC-UV and LC-MS assays for therapeutic drug monitoring of ertapenem in human plasma
    Pickering, Matthew
    Brown, Stacy
    BIOMEDICAL CHROMATOGRAPHY, 2013, 27 (05) : 568 - 574
  • [10] Development and validation of an integrated LC-MS/MS assay for therapeutic drug monitoring of five PARP-inhibitors
    Bruin, M. A. C.
    de Vries, N.
    Lucas, L.
    Rosing, H.
    Huitema, A. D. R.
    Beijnen, J. H.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2020, 1138 (1138):
123